{"id":1737304,"date":"2025-01-14T20:23:48","date_gmt":"2025-01-14T14:53:48","guid":{"rendered":"https:\/\/pharmint.net\/?p=1737304"},"modified":"2025-07-31T17:05:20","modified_gmt":"2025-07-31T11:35:20","slug":"top-challenges-in-pharma-procurement-and-how-to-solve-them","status":"publish","type":"post","link":"https:\/\/pharmint.net\/zh\/top-challenges-in-pharma-procurement-and-how-to-solve-them\/","title":{"rendered":"Top 7 Challenges in Pharma Procurement and How to Solve Them"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_74 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/pharmint.net\/zh\/top-challenges-in-pharma-procurement-and-how-to-solve-them\/#Key_Takeaways_Pharma_Procurement_Challenges_Solutions\" >Key Takeaways:&nbsp;Pharma Procurement Challenges &amp; Solutions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/pharmint.net\/zh\/top-challenges-in-pharma-procurement-and-how-to-solve-them\/#Pharma_Procurement_Overview_Scope_Complexity_and_Risks\" >Pharma Procurement Overview: Scope, Complexity, and Risks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/pharmint.net\/zh\/top-challenges-in-pharma-procurement-and-how-to-solve-them\/#7_Major_Procurement_Challenges_and_Their_Solutions\" >7 Major Procurement Challenges and Their Solutions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/pharmint.net\/zh\/top-challenges-in-pharma-procurement-and-how-to-solve-them\/#Pharmacology_Procurement_Strategy\" >Pharmacology Procurement Strategy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/pharmint.net\/zh\/top-challenges-in-pharma-procurement-and-how-to-solve-them\/#How_Pharmint_Supports_Efficient_Pharma_Procurement\" >How Pharmint Supports Efficient Pharma Procurement?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/pharmint.net\/zh\/top-challenges-in-pharma-procurement-and-how-to-solve-them\/#Final_Thoughts\" >Final Thoughts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/pharmint.net\/zh\/top-challenges-in-pharma-procurement-and-how-to-solve-them\/#Pharma_Procurement_Challenges_FAQs\" >Pharma Procurement Challenges FAQs&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/pharmint.net\/zh\/top-challenges-in-pharma-procurement-and-how-to-solve-them\/#References_Used\" >References Used:<\/a><\/li><\/ul><\/nav><\/div>\n<h4><em><strong>Why Pharma Procurement Challenges Demand Strategic Solutions?<\/strong><\/em><\/h4>\n<p>Pharmaceutical procurement is a high-stakes function that directly impacts medicine availability, regulatory compliance, and patient safety. The World Health Organization estimates that over&nbsp;<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2949856224000011\" target=\"_blank\" rel=\"noopener\"><strong>30% of global health spending<\/strong><\/a>&nbsp;is lost due to inefficiencies in procurement and supply chains. In low- and middle-income countries,&nbsp;<strong>1 in 10 medical products<\/strong>&nbsp;is substandard or falsified&mdash;often due to weak sourcing controls.<\/p>\n<div style=\"background-color: #e6f4f9; border-left: 4px solid #1c7cbf; padding: 16px; margin: 24px 0; border-radius: 4px; font-family: Arial, sans-serif;\">\n<h2 style=\"margin-top: 0; color: #1c7cbf;\"><span class=\"ez-toc-section\" id=\"Key_Takeaways_Pharma_Procurement_Challenges_Solutions\"><\/span><span id=\"Key_Takeaways\" class=\"ez-toc-section\"><\/span><strong>Key Takeaways:&nbsp;Pharma Procurement Challenges &amp; Solutions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span style=\"font-weight: 400;\">Pharmaceutical procurement faces six key challenges:<\/span><\/h3>\n<ul>\n<li style=\"font-weight: 400;\"><strong><span style=\"color: #ff0000;\">Challenge 1<\/span>: Quality assurance issues &ndash;<\/strong><span style=\"font-weight: 400;\"> Enforce GMP compliance and strengthen supplier audits.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong><span style=\"color: #ff0000;\">Challenge 2:<\/span> Regulatory and compliance complexity <\/strong><strong><em>&ndash; <\/em><\/strong><span style=\"font-weight: 400;\">Standardize documentation and train procurement teams on global regulations.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong><span style=\"color: #ff0000;\">Challenge 3:<\/span> Supply chain disruptions &ndash; <\/strong><span style=\"font-weight: 400;\">Use dual sourcing and diversify logistics networks.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong><span style=\"color: #ff0000;\">Challenge 4:<\/span> Cost volatility &ndash; <\/strong><span style=\"font-weight: 400;\">Lock in pricing contracts and use spend analytics to predict fluctuations.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong><span style=\"color: #ff0000;\">Challenge 5:<\/span> Limited digital transformation &ndash;<\/strong><span style=\"font-weight: 400;\"> Integrate e-procurement systems and enhance supply chain visibility.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong><span style=\"color: #ff0000;\">Challenge 6:<\/span> Counterfeit products &ndash; <\/strong><span style=\"font-weight: 400;\">Adopt serialization, blockchain, and licensed distributor verification.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong><span style=\"color: #ff0000;\">Challenge 7:<\/span> Managing Diverse Product Categories: <\/strong><span style=\"font-weight: 400;\">Segment procurement by product type and regulatory class.<\/span><\/li>\n<\/ul>\n<\/div>\n<p>Pharma companies also face rising complexity: according to McKinsey,&nbsp;<strong>over 70% of biopharma executives<\/strong>&nbsp;cite procurement disruptions as a top risk to operational continuity. With increasing global interdependencies, cold-chain requirements, and compliance obligations, even a minor procurement failure can trigger cascading delays or legal consequences.<\/p>\n<p>This guide breaks down the&nbsp;<strong>top challenges in pharmaceutical procurement and provides actionable solutions<\/strong>. Each section aligns with real-world risks and offers strategies to improve resilience, reduce costs, and safeguard patient outcomes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pharma_Procurement_Overview_Scope_Complexity_and_Risks\"><\/span><strong>Pharma Procurement Overview: Scope, Complexity, and Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pharma procurement involves sourcing medicines,&nbsp;<a href=\"https:\/\/pharmint.net\/product-category\/pharma-ingredients-raw-materials\/\">APIs<\/a>, diagnostics, and&nbsp;<a href=\"https:\/\/pharmint.net\/product-category\/medical-equipments\/\">medical supplies<\/a>&nbsp;under strict regulatory and quality standards. Unlike general procurement, it must align with global health laws, ensure traceability, and manage life-critical inventory.<\/p>\n<p>Over&nbsp;<strong>10% of medicines in low-income countries<\/strong>&nbsp;are substandard or falsified (<a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/substandard-and-falsified-medical-products\" target=\"_blank\" rel=\"noopener\">WHO, 2024)<\/a>, often due to poor procurement practices. The COVID-19 pandemic revealed additional weaknesses, with&nbsp;<strong>70% of companies<\/strong>&nbsp;reporting supply chain failures (<a href=\"https:\/\/www.mckinsey.com\/~\/media\/mckinsey\/business%20functions\/operations\/our%20insights\/risk%20resilience%20and%20rebalancing%20in%20global%20value%20chains\/risk-resilience-and-rebalancing-in-global-value-chains-full-report-vh.pdf\" target=\"_blank\" rel=\"noopener\">McKinsey&nbsp;<\/a>).<\/p>\n<p><strong>Key challenges include:<\/strong><\/p>\n<ul>\n<li>Cold-chain management for temperature-sensitive drugs<\/li>\n<li>Regulatory variation across international markets<\/li>\n<li>Expiry risks due to delivery delays<\/li>\n<li>Ethical and patient safety implications of sourcing errors<\/li>\n<\/ul>\n<p>Effective procurement requires validated suppliers, regulatory alignment, and digital oversight tools.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"7_Major_Procurement_Challenges_and_Their_Solutions\"><\/span><strong>7 Major Procurement Challenges and Their Solutions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The following sections outline the most common obstacles in pharma procurement and how to address them using regulatory-compliant, data-driven strategies.<\/p>\n<h3><strong>1. Sourcing Quality Products from Reliable Suppliers<\/strong><\/h3>\n<p>Poor-quality sourcing leads to compliance violations, treatment failure, and patient risk. WHO data shows&nbsp;<strong>10% of medicines in low-income regions are substandard or falsified<\/strong>, often due to weak supplier verification.<\/p>\n<p><strong>Solution:<\/strong><strong><br>\n<\/strong>Work only with GMP-certified suppliers. Require certificates of analysis, audit reports, and validated quality systems. Use internal SOPs to qualify and requalify vendors on a set schedule.<\/p>\n<p><strong>Best Practices:<\/strong><\/p>\n<ul>\n<li>Request regulatory certifications (GMP, GDP, ISO)<\/li>\n<li>Require product CoAs and batch-level documentation<\/li>\n<li>Perform routine audits and background checks on vendors<\/li>\n<li>Establish supplier scorecards based on quality and delivery metrics<\/li>\n<\/ul>\n<h3><strong>2. Regulatory and Compliance Issues<\/strong><\/h3>\n<p>Pharma procurement must comply with regional and international regulations. Errors in documentation, storage, or supplier compliance can result in shipment delays, penalties, or product seizures. Regulatory requirements vary across markets&mdash;such as FDA, EMA, and CDSCO standards&mdash;making compliance more complex for cross-border sourcing.<\/p>\n<p><strong>Solution:<\/strong><strong><br>\n<\/strong>Track compliance using a centralized regulatory checklist by country. Only source from suppliers with valid GMP, GDP, or ISO certifications. Maintain <a href=\"https:\/\/pharmint.net\/zh\/glossary\/audit-trail\/\" target=\"_self\" title=\"What Is an Audit Trail? An audit trail is like a digital logbook&nbsp;that automatically records every important action in a system. It shows&nbsp;who did what, when, and where, and keeps track of any changes made. This helps ensure accuracy, accountability, and transparency in regulated industries like pharmaceuticals. Why Are Audit Trails Essential in Pharmaceutical Compliance?&hellip;\" class=\"encyclopedia\">audit trail<\/a>s for all transactions.<\/p>\n<p><strong>Best Practices:<\/strong><\/p>\n<ul>\n<li>Verify all suppliers against national health authority databases<\/li>\n<li>Use serialization-compliant vendors to meet global traceability laws<\/li>\n<li>Schedule routine audits and compliance refreshers for procurement teams<\/li>\n<li>Require suppliers to submit updated licenses and CoAs with every batch<\/li>\n<\/ul>\n<h3><strong>3. Supply Chain Disruptions<\/strong><\/h3>\n<p>Global crises, geopolitical conflicts, and transport bottlenecks frequently disrupt <a href=\"https:\/\/pharmint.net\/zh\/glossary\/pharmaceutical-supply-chain\/\" target=\"_self\" title=\"What is the Pharmaceutical Supply Chain? The&nbsp;Pharma Supply Chain&nbsp;is the network of interconnected stages and stakeholders involved in sourcing&nbsp;raw materials&nbsp;(&nbsp;APIs,&nbsp;excipients, intermediates), manufacturing finished drug products, packaging, distribution, and delivering medicines safely to healthcare providers, pharmacies, hospitals, and ultimately patients. Why Does the Pharma Supply Chain Matter? Ensures&nbsp;quality, safety, and efficacy&nbsp;of medicines throughout the journey. Helps&hellip;\" class=\"encyclopedia\">pharmaceutical supply chain<\/a>s. During the COVID-19 pandemic, over&nbsp;<strong>70% of pharmaceutical companies<\/strong>&nbsp;experienced material shortages or delayed shipments, exposing critical weaknesses in procurement planning. [<a href=\"https:\/\/www.researchgate.net\/publication\/385439907_Exploring_the_critical_factors_in_pharmaceutical_supply_chains_revealed_during_COVID-19_and_addressing_missing_links\" target=\"_blank\" rel=\"noopener\">source<\/a>]<\/p>\n<p><strong>Solution:<\/strong><strong><br>\n<\/strong>Mitigate risk by implementing dual-sourcing strategies and maintaining safety stock for critical items. Map supply chain dependencies to identify single points of failure.<\/p>\n<p><strong>Best Practices:<\/strong><\/p>\n<ul>\n<li>Use vendor diversification to avoid over-reliance on a single supplier or region<\/li>\n<li>Maintain buffer inventory for high-priority SKUs with long <a href=\"https:\/\/pharmint.net\/zh\/glossary\/lead-time\/\" target=\"_self\" title=\"What Is Lead Time in Pharmaceutical Operations? Lead Time&nbsp;is the total duration from the initiation of a process (e.g., ordering materials) to its completion (e.g., receiving the finished product). This includes all steps from sourcing&nbsp;raw materials&nbsp;through manufacturing and&nbsp;quality control, to final delivery. Why Is Lead Time Important in Pharma? Operational Planning: Understanding lead times helps&hellip;\" class=\"encyclopedia\">lead time<\/a>s<\/li>\n<li>Implement scenario planning tools to model disruption responses<\/li>\n<li>Monitor logistics corridors for delay-prone routes or customs risks<\/li>\n<\/ul>\n<h3><strong>4. Price Volatility<\/strong><\/h3>\n<p><a href=\"https:\/\/pharmint.net\/zh\/glossary\/raw-material\/\" target=\"_self\" title=\"What Is a Raw Material in Pharmaceutical Manufacturing? A&nbsp;raw material&nbsp;in the pharmaceutical industry refers to any unprocessed or minimally processed substance used at the beginning of a synthesis or formulation process. These materials include solvents, reagents, minerals, plant extracts, and basic chemicals that transform the manufacture of pharmaceutical intermediates, APIs, or excipients. Why Are Raw&hellip;\" class=\"encyclopedia\">Raw material<\/a> costs, fuel prices, and currency fluctuations make pharmaceutical procurement unpredictable. Price spikes during global crises or supply shortages can erode profit margins and disrupt budgeting for public tenders or long-term contracts.<\/p>\n<p><strong>Solution:<\/strong><strong><br>\n<\/strong>Stabilize costs by negotiating long-term contracts with pricing clauses tied to market indices. Monitor commodity trends and factor currency risks into supplier agreements.<\/p>\n<p><strong>Best Practices:<\/strong><\/p>\n<ul>\n<li>Use historical pricing data to benchmark supplier quotes<\/li>\n<li>Establish buffer budgets for volatile APIs or rare compounds<\/li>\n<li>Include price-adjustment terms in contracts for sustained supply<\/li>\n<li>Diversify supplier geography to reduce exposure to currency shifts<\/li>\n<\/ul>\n<h3><strong>5. Technological Integration<\/strong><\/h3>\n<p>Manual procurement processes increase errors, reduce visibility, and delay decision-making. Many pharma companies still rely on spreadsheets or disconnected systems, limiting their ability to track supplier performance, regulatory compliance, and real-time inventory levels.<\/p>\n<p><strong>Solution:<\/strong><strong><br>\n<\/strong>Adopt digital procurement tools that automate vendor onboarding, order tracking, and compliance checks. Integrate procurement platforms with ERP and quality systems to centralize data and improve traceability.<\/p>\n<p><strong>Best Practices:<\/strong><\/p>\n<ul>\n<li>Use e-procurement systems with built-in compliance workflows<\/li>\n<li>Implement dashboards to track supplier KPIs and delivery timelines<\/li>\n<li>Enable automated alerts for expiring certifications or delayed shipments<\/li>\n<li>Integrate digital audits and document management for GMP traceability<\/li>\n<\/ul>\n<h3><strong>6. Product Counterfeiting<\/strong><\/h3>\n<p>Counterfeit pharmaceuticals threaten patient safety, damage brand trust, and expose companies to regulatory action. WHO estimates that&nbsp;<strong>up to 10% of medicines globally<\/strong>&nbsp;are counterfeit, with higher rates in unregulated markets and online channels. [<a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/substandard-and-falsified-medical-products\" target=\"_blank\" rel=\"noopener\">source<\/a>]<\/p>\n<p><strong>Solution:<\/strong><strong><br>\n<\/strong>Source only from licensed suppliers with serialization-compliant systems. Implement end-to-end product traceability using barcodes or RFID. Verify batch numbers and certificates before accepting deliveries.<\/p>\n<p><strong>Best Practices:<\/strong><\/p>\n<ul>\n<li>Require serialization and tamper-evident packaging from all vendors<\/li>\n<li>Cross-check supplier licenses with national health databases<\/li>\n<li>Use authentication tools (e.g., QR codes) to verify product legitimacy<\/li>\n<li>Train procurement and warehouse staff to detect counterfeit indicators<\/li>\n<\/ul>\n<h3><strong>7. Managing Diverse Product Categories<\/strong><\/h3>\n<p>Procurement teams often handle a wide range of pharmaceutical categories&mdash;each with unique storage, compliance, and sourcing requirements. Managing APIs, vaccines, diagnostic kits, and over-the-counter (OTC) products under one workflow increases operational complexity.<\/p>\n<p><strong>Solution:<\/strong><strong><br>\n<\/strong>Segment procurement by product type and regulatory class. Assign specialized sourcing protocols, documentation requirements, and approved supplier lists per category.<\/p>\n<p><strong>Best Practices:<\/strong><\/p>\n<ul>\n<li>Create category-specific procurement SOPs (e.g., cold-chain, <a href=\"https:\/\/pharmint.net\/zh\/glossary\/controlled-substance\/\" target=\"_self\" title=\"What Is a Controlled Substance? A&nbsp;controlled substance&nbsp;is a drug, chemical, or precursor regulated by law due to potential for abuse, addiction, or public health threat. These are classified into schedules based on medical utility, abuse risk, and safety, reflecting stringent national and international control frameworks. Why Is Regulation of Controlled Substances Crucial? Strict governance ensures:&hellip;\" class=\"encyclopedia\">controlled substance<\/a>s)<\/li>\n<li>Maintain separate vendor databases for high-risk or high-value products<\/li>\n<li>Standardize documentation requirements by category (e.g., MSDS, CoA, import licenses)<\/li>\n<li>Use procurement dashboards that filter and track items by category<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Pharmacology_Procurement_Strategy\"><\/span><strong>Pharmacology Procurement Strategy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Effective pharmacology procurement requires more than transactional buying; it demands alignment with therapeutic value, clinical need, and regulatory frameworks. Unlike general pharma sourcing, pharmacology procurement focuses on ensuring that drug categories are procured based on efficacy, patient safety, and treatment protocols.<\/p>\n<p>This includes anticipating demand for chronic vs. acute medications, sourcing based on pharmacokinetic profiles, and ensuring batch consistency for therapeutic equivalence.<\/p>\n<p><strong>Strategic Approaches:<\/strong><\/p>\n<ul>\n<li>Prioritize drugs with narrow therapeutic index (NTI) for strict batch validation<\/li>\n<li>Align procurement with formulary committees or treatment protocols<\/li>\n<li>Classify drugs by mechanism of action for structured sourcing<\/li>\n<li>Integrate pharmacovigilance feedback into reorder decisions<\/li>\n<li>Review bioequivalence data for generics before substitution<\/li>\n<\/ul>\n<p>A <a href=\"https:\/\/pharmint.net\/pharmaceutical-procurement-strategies\/\" target=\"_blank\" rel=\"noopener\">clinically informed pharma procurement strategy<\/a> helps minimize variability in therapeutic sourcing, supports alignment with treatment protocols, and strengthens regulatory adherence throughout the procurement process.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Pharmint_Supports_Efficient_Pharma_Procurement\"><\/span><strong>How Pharmint Supports Efficient Pharma Procurement?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pharmint offers a structured B2B marketplace designed to address core pharmaceutical procurement challenges. It connects buyers with&nbsp;<strong>GMP- and GDP-compliant suppliers<\/strong>&nbsp;across categories such as APIs, finished formulations, diagnostics, and medical equipment.<\/p>\n<p>By consolidating sourcing into a single platform, Pharmint reduces manual vendor searches, supports regulatory compliance, and enables better price discovery.<\/p>\n<p><strong>Key Capabilities Include:<\/strong><\/p>\n<ul>\n<li>Verified supplier network with up-to-date certifications<\/li>\n<li>Category-based sourcing for <a href=\"https:\/\/pharmint.net\/zh\/glossary\/raw-material\/\" target=\"_self\" title=\"What Is a Raw Material in Pharmaceutical Manufacturing? A&nbsp;raw material&nbsp;in the pharmaceutical industry refers to any unprocessed or minimally processed substance used at the beginning of a synthesis or formulation process. These materials include solvents, reagents, minerals, plant extracts, and basic chemicals that transform the manufacture of pharmaceutical intermediates, APIs, or excipients. Why Are Raw&hellip;\" class=\"encyclopedia\">raw material<\/a>s, generics, and diagnostics<\/li>\n<li>Document tracking (CoAs, licenses, audits) per transaction<\/li>\n<li>Transparent pricing tools for better procurement planning<\/li>\n<li>Support for cross-border procurement with documentation compliance<\/li>\n<\/ul>\n<p>Pharmint simplifies the procurement workflow by offering traceability, supplier credibility, and access to diverse product categories in a centralized digital environment.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts\"><\/span><strong>Final Thoughts<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pharma procurement today involves far more than cost negotiation. It requires managing regulatory risks, quality assurance, technological integration, and supply chain volatility&mdash;often across multiple countries and product classes. By adopting best practices, leveraging digital tools, and working with verified suppliers, procurement leaders can build more resilient and compliant sourcing strategies.<\/p>\n<p>A&nbsp;<a href=\"https:\/\/pharmint.net\/\">B2B Pharmaceutical&nbsp;<\/a><a href=\"https:\/\/pharmint.net\/\">platform<\/a>&nbsp;like Pharmint, designed specifically for the pharmaceutical ecosystem, helps streamline this process while meeting global quality and regulatory standards.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pharma_Procurement_Challenges_FAQs\"><\/span><strong>Pharma Procurement Challenges FAQs&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h4><strong>What documents are required to import pharmaceutical raw materials?<\/strong><\/h4>\n<p>Importing pharma <a href=\"https:\/\/pharmint.net\/zh\/glossary\/raw-material\/\" target=\"_self\" title=\"What Is a Raw Material in Pharmaceutical Manufacturing? A&nbsp;raw material&nbsp;in the pharmaceutical industry refers to any unprocessed or minimally processed substance used at the beginning of a synthesis or formulation process. These materials include solvents, reagents, minerals, plant extracts, and basic chemicals that transform the manufacture of pharmaceutical intermediates, APIs, or excipients. Why Are Raw&hellip;\" class=\"encyclopedia\">raw material<\/a>s requires a valid drug license, purchase order, GMP certificate, <a href=\"https:\/\/pharmint.net\/zh\/glossary\/certificate-of-analysis-coa\/\" target=\"_self\" title=\"What Is a Certificate of Analysis (COA)? A&nbsp;Certificate of Analysis (COA)&nbsp;is an official, batch-specific document issued by a manufacturer or quality control lab that verifies a product's identity, strength, purity, and conformance to predefined specifications. It's essential for quality assurance and regulatory compliance across&nbsp;APIs,&nbsp;excipients,&nbsp;drugs, and reference materials. Why Is a COA Important in the Pharma&hellip;\" class=\"encyclopedia\">certificate of analysis (CoA)<\/a>, and customs clearance documentation based on national regulations.<\/p>\n<h4><strong>How do I verify if a pharmaceutical supplier is GMP-certified?<\/strong><\/h4>\n<p><a href=\"https:\/\/pharmint.net\/gmp-certified-api-manufacturers\/\">Verify GMP certification<\/a>&nbsp;by checking the supplier&rsquo;s license number with national drug regulatory portals or requesting audit reports and official GMP certificates from authorized bodies.<\/p>\n<h4><strong>What is the difference between GDP and GMP in pharma procurement?<\/strong><\/h4>\n<p>GMP covers manufacturing quality standards, while GDP ensures proper distribution and storage. Both are essential to maintain product integrity from production to delivery.<\/p>\n<h4><strong>How do cold-chain requirements affect pharmaceutical sourcing?<\/strong><\/h4>\n<p>Cold-chain sourcing requires temperature-controlled logistics, validated packaging, and real-time monitoring to maintain drug efficacy and comply with Good Distribution Practices (GDP).<\/p>\n<h4><strong>What KPIs should I track in pharma procurement performance?<\/strong><\/h4>\n<p>Track on-time delivery rate, supplier defect rate, cost savings, stock-out frequency, and contract compliance to evaluate procurement effectiveness and risk exposure.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"References_Used\"><\/span>References Used:<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/substandard-and-falsified-medical-products\" target=\"_blank\" rel=\"noopener\">https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/substandard-and-falsified-medical-products<\/a><\/li>\n<li><a href=\"https:\/\/www.mckinsey.com\/~\/media\/mckinsey\/business%20functions\/operations\/our%20insights\/risk%20resilience%20and%20rebalancing%20in%20global%20value%20chains\/risk-resilience-and-rebalancing-in-global-value-chains-full-report-vh.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/www.mckinsey.com\/~\/media\/mckinsey\/business%20functions\/operations\/our%20insights\/risk%20resilience%20and%20rebalancing%20in%20global%20value%20chains\/risk-resilience-and-rebalancing-in-global-value-chains-full-report-vh.pdf<\/a><\/li>\n<li><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2949856224000011\" target=\"_blank\" rel=\"noopener\">https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2949856224000011<\/a><\/li>\n<li><a href=\"https:\/\/www.researchgate.net\/publication\/385439907_Exploring_the_critical_factors_in_pharmaceutical_supply_chains_revealed_during_COVID-19_and_addressing_missing_links\" target=\"_blank\" rel=\"noopener\">https:\/\/www.researchgate.net\/publication\/385439907_Exploring_the_critical_factors_in_pharmaceutical_supply_chains_revealed_during_COVID-19_and_addressing_missing_links<\/a><\/li>\n<li><a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/substandard-and-falsified-medical-products\" target=\"_blank\" rel=\"noopener\">https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/substandard-and-falsified-medical-products<\/a><\/li>\n<\/ul>\n<h2><\/h2>\n","protected":false},"excerpt":{"rendered":"<p>Why Pharma Procurement Challenges Demand Strategic Solutions? Pharmaceutical procurement is a high-stakes function that directly impacts medicine availability, regulatory compliance, and patient safety. The World Health Organization estimates that over\u00a030% of global health spending\u00a0is lost due to inefficiencies in procurement and supply chains. In low- and middle-income countries,\u00a01 in 10 medical products\u00a0is substandard or falsified\u2014often [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1737318,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ep_exclude_from_search":false,"footnotes":""},"categories":[827],"tags":[],"class_list":["post-1737304","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/pharmint.net\/zh\/wp-json\/wp\/v2\/posts\/1737304","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmint.net\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmint.net\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmint.net\/zh\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmint.net\/zh\/wp-json\/wp\/v2\/comments?post=1737304"}],"version-history":[{"count":6,"href":"https:\/\/pharmint.net\/zh\/wp-json\/wp\/v2\/posts\/1737304\/revisions"}],"predecessor-version":[{"id":1737940,"href":"https:\/\/pharmint.net\/zh\/wp-json\/wp\/v2\/posts\/1737304\/revisions\/1737940"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmint.net\/zh\/wp-json\/wp\/v2\/media\/1737318"}],"wp:attachment":[{"href":"https:\/\/pharmint.net\/zh\/wp-json\/wp\/v2\/media?parent=1737304"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmint.net\/zh\/wp-json\/wp\/v2\/categories?post=1737304"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmint.net\/zh\/wp-json\/wp\/v2\/tags?post=1737304"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}